Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Press release – No. 18 / 2023 Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome Copenhagen, Denmark, December 22, 2023 – Zealand Pharma A/S...